CCLEAREX.MARKET
Join free
Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook
Market IntelligencePublic

Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Investing.com·July 16, 2026·1 min read
Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook
Read full article on Investing.com

Share this article

Follow broker incidents, regulatory actions & market intelligence

Stay ahead with CLEAREX.MARKET

View all intelligence →
Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook